Paper Review Records
All Paper Review Records
24 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
96
days
Strengthening Signal Detection by Proactive Adverse Event Case Identification in Electronic Health Records Using a Text-Mining Tool
Authors
Gabriëlla von Kreijfelt; Juliëtte Zwaveling; Jette A. van Lint; Loes E. Visser; Agnes C. KantShow moreShow less
Affiliations
1. The Netherlands Pharmacovigilance Centre Lareb, ‘s-Hertogenbosch, The Netherlands; 2. Department of Clinical Pharmacology and Toxicology, Leiden University Medical Centre, Leiden, The Netherlands; 3. Department of Pharmacy, Haga Teaching Hospital, The Hague, The Netherlands; 4. Hospital Pharmacy, Erasmus Medical Centre, Rotterdam, The NetherlandsShow moreShow less
88
days
Current Pharmacovigilance Outsourcing Practices in Arab Countries
Authors
Ibrahim Abdeldayem; Thamir M Alshammari; Karine PalinShow moreShow less
Affiliations
1. Arriello s.r.o, Prague, Czech Republic; 2. Eu2P Programme, Université de Bordeaux, Bordeaux, France; 3. Department of Pharmacy Practice, College of Pharmacy, Jazan University, Jazan, Saudi Arabia; 4. Pharmacy Practice Research Unit, College of Pharmacy, Jazan University, Jazan, Saudi ArabiaShow moreShow less
108
days
Reassessing the Neoplasm Signal with Fezolinetant: Regulatory Inference, Mechanistic Plausibility, and the Case for Proactive Pharmacovigilance
Authors
Glen Clack; Jennifer RenwickShow moreShow less
Affiliations
1. Ailse Oncology Ltd and University of Sheffield Medical School, Sheffield, Truro, UK; 2. Independent Pharmaceutical Consultant, London, UKShow moreShow less
87
days
Safety Monitoring of COVID-19 Vaccines in the Vaccine Adverse Event Reporting System (VAERS): United States, August 22, 2024–July 4, 2025
Authors
Brittney Romanson; Pedro L. Moro; Penelope Strid; Anne Hause; Erin Stroud; Paige L. Marquez; Bicheng Zhang; Carol Ennulat; Hannah Brown; John R. SuShow moreShow less
Affiliations
1. Division of Healthcare Quality and Promotion, National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Centers for Disease Control and Prevention (CDC), Atlanta, USA; 2. Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, CanadaShow moreShow less
4
days
ISoP MENA Chapter: Strategic Development and Future Directions Following a Decade of Strengthening Pharmacovigilance in the Middle East and North Africa
Authors
Hadir Rostom; Mohamed A. Elhawary; Mayada Alkhakany; Manal M. Younus; Thamir Alshammari; Felipe Villalobos; Omar AimerShow moreShow less
Affiliations
1. ISoP MENA Chapter Founding Group, Cairo, Egypt; 2. Faculty of Pharmacy, MSA University, 6th of October City, Egypt; 3. International Society of Pharmacovigilance, ISoP Secretariat Ltd, London, UK; 4. Medical Affairs, SAJA Pharmaceuticals Co., Ltd, Jeddah, Saudi Arabia; 5. Seven D Consultancy, Dubai, UAE; 6. Iraqi Pharmacovigilance Centre, Ministry of Health, Baghdad, Iraq; 7. Department of Pharmacy Practice, College of Pharmacy, Jazan University, Jazan, Saudi Arabia; 8. Pharmacy Practice Research Unit, College of Pharmacy, Jazan University, Jazan, Saudi Arabia; 9. Fundació Institut Universitari per a la Recerca a l’Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain; 10. InnoVigilance, Laval, CanadaShow moreShow less
288
days
Safety and Management of Targeted Therapies for Relapsed/Refractory Chronic Lymphocytic Leukemia
Authors
Sikander Ailawadhi; Elcin Omercikoglu; Aneel Paulus; Ricardo D. Parrondo; Asher A. Chanan-KhanShow moreShow less
Affiliations
1. Division of Hematology-Oncology, Mayo Clinic, Jacksonville, USA; 2. Department of Cancer Biology, Mayo Clinic, Jacksonville, USAShow moreShow less
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
